图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
真核基因表达评论综述™
影响因子: 1.841 5年影响因子: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN 打印: 1045-4403
ISSN 在线: 2162-6502

真核基因表达评论综述™

DOI: 10.1615/CritRevEukarGeneExpr.v19.i1.20
pages 47-60

Cancer Treatment-Related Bone Disease

Sue A. Brown
Department of Medicine, University of Virginia, Charlottesville, Virginia, USA
Theresa A. Guise
Division of Endocrinology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900

ABSTRACT

Bone health may be impaired in many patients being treated for cancer. Primary tumors that reside in or form metastases to bone can result in compromised skeletal integrity. It has also been increasingly recognized that patients undergoing therapies for treatment of cancer are at higher risk of bone loss. These include androgen-deprivation therapy for prostate cancer and aromatase inhibitor therapy for breast cancer, among others. Hypogonadism induced by many of these cancer treatments results in bone loss and increases the risk of osteoporosis and fractures. Progress has been made in identifying the role of oral and intravenous bisphosphonates to prevent bone loss in these patients. This review discusses bone loss associated with cancer treatments, with a focus on breast cancer, prostate cancer, and survivors of childhood malignancies.


Articles with similar content:

Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 4
Munira Momin, Chintan Bhavsar, Sankalp A. Gharat
Skeletal Muscle Adaptations to Cancer and its Treatment: Their Fundamental Basis and Contribution to Functional Disability
Critical Reviews™ in Eukaryotic Gene Expression, Vol.23, 2013, issue 4
Kim Dittus, Hirak Der-Torossian, Marion E. Couch, Michael J. Toth
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Maurizio Soresi, Giuseppe Montalto, Lydia Giannitrapani, Walter Grana, Anna Licata
Gene Therapy for Lung Cancer
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 1-2
Humberto Lara-Guerra, Jack A. Roth
Cellular Iron Metabolism in Prognosis and Therapy of Breast Cancer
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 5
Frank M. Torti, Suzy V. Torti